Robert W. Baird Reaffirms Buy Rating for Envision Healthcare Corporation (NYSE:EVHC)

Robert W. Baird reaffirmed their buy rating on shares of Envision Healthcare Corporation (NYSE:EVHC) in a research note released on Tuesday, October 17th. Robert W. Baird currently has a $70.00 price objective on the stock.

Several other equities research analysts also recently weighed in on the stock. Zacks Investment Research raised shares of Envision Healthcare Corporation from a strong sell rating to a buy rating and set a $70.00 price target for the company in a research note on Tuesday, July 4th. Jefferies Group LLC set a $71.00 target price on shares of Envision Healthcare Corporation and gave the stock a buy rating in a research report on Thursday, August 24th. Bank of America Corporation decreased their target price on shares of Envision Healthcare Corporation from $72.00 to $60.00 and set a buy rating for the company in a research report on Monday, October 9th. SunTrust Banks, Inc. set a $55.00 target price on shares of Envision Healthcare Corporation and gave the stock a buy rating in a research report on Sunday, October 15th. Finally, Royal Bank Of Canada boosted their target price on shares of Envision Healthcare Corporation from $72.00 to $77.00 and gave the stock an outperform rating in a research report on Tuesday, June 27th. Two equities research analysts have rated the stock with a sell rating, five have issued a hold rating, ten have issued a buy rating and one has assigned a strong buy rating to the company’s stock. Envision Healthcare Corporation presently has an average rating of Buy and an average price target of $49.21.

Shares of Envision Healthcare Corporation (EVHC) traded down $0.25 during trading on Tuesday, reaching $26.79. 3,316,537 shares of the company’s stock were exchanged, compared to its average volume of 4,380,000. Envision Healthcare Corporation has a 1 year low of $26.34 and a 1 year high of $74.75. The company has a debt-to-equity ratio of 0.89, a current ratio of 3.01 and a quick ratio of 3.00. The firm has a market capitalization of $3,270.00, a price-to-earnings ratio of 8.35, a P/E/G ratio of 0.58 and a beta of 0.69.

Envision Healthcare Corporation (NYSE:EVHC) last issued its quarterly earnings results on Tuesday, October 31st. The company reported $0.73 EPS for the quarter, missing analysts’ consensus estimates of $0.81 by ($0.08). Envision Healthcare Corporation had a positive return on equity of 4.88% and a negative net margin of 6.39%. The business had revenue of $1.99 billion for the quarter, compared to analyst estimates of $2.03 billion. During the same quarter last year, the firm posted $1.13 EPS. Envision Healthcare Corporation’s revenue for the quarter was up 142.0% on a year-over-year basis. research analysts expect that Envision Healthcare Corporation will post 3.12 earnings per share for the current year.

COPYRIGHT VIOLATION NOTICE: “Robert W. Baird Reaffirms Buy Rating for Envision Healthcare Corporation (NYSE:EVHC)” was posted by BBNS and is owned by of BBNS. If you are viewing this article on another site, it was copied illegally and republished in violation of US & international trademark and copyright law. The correct version of this article can be viewed at https://baseballnewssource.com/markets/envision-healthcare-corporations-evhc-buy-rating-reaffirmed-at-robert-w-baird/1721670.html.

Envision Healthcare Corporation announced that its board has authorized a share repurchase plan on Monday, September 18th that permits the company to buyback $250.00 million in shares. This buyback authorization permits the company to purchase up to 4.5% of its stock through open market purchases. Stock buyback plans are often an indication that the company’s board believes its shares are undervalued.

Several hedge funds and other institutional investors have recently made changes to their positions in EVHC. BlackRock Inc. boosted its holdings in shares of Envision Healthcare Corporation by 3,895.0% during the 1st quarter. BlackRock Inc. now owns 7,197,631 shares of the company’s stock valued at $441,359,000 after acquiring an additional 7,017,467 shares during the last quarter. Janus Henderson Group PLC boosted its holdings in shares of Envision Healthcare Corporation by 36,086.8% in the second quarter. Janus Henderson Group PLC now owns 3,945,087 shares of the company’s stock worth $247,239,000 after buying an additional 3,934,185 shares during the last quarter. Maverick Capital Ltd. boosted its holdings in shares of Envision Healthcare Corporation by 66.2% in the second quarter. Maverick Capital Ltd. now owns 5,093,292 shares of the company’s stock worth $319,197,000 after buying an additional 2,028,026 shares during the last quarter. Janus Capital Management LLC boosted its holdings in shares of Envision Healthcare Corporation by 63.7% in the first quarter. Janus Capital Management LLC now owns 2,712,066 shares of the company’s stock worth $167,536,000 after buying an additional 1,055,014 shares during the last quarter. Finally, Lord Abbett & CO. LLC boosted its holdings in shares of Envision Healthcare Corporation by 259.6% in the second quarter. Lord Abbett & CO. LLC now owns 1,321,328 shares of the company’s stock worth $82,808,000 after buying an additional 953,928 shares during the last quarter.

Envision Healthcare Corporation Company Profile

Envision Healthcare Holdings, Inc, formerly CDRT Holding Corporation, is a holding company. The Company, through its subsidiary, provides physician-led medical services in the United States. It operates in two segments: EmCare Holdings, Inc (EmCare) and American Medical Response, Inc (AMR). Its EmCare segment is a provider of integrated facility-based and post-acute care physician services to healthcare facilities in the United States.

Analyst Recommendations for Envision Healthcare Corporation (NYSE:EVHC)

Receive News & Ratings for Envision Healthcare Corporation Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Envision Healthcare Corporation and related companies with our FREE daily email newsletter.

 


Latest News

Seattle Mariners Start Offseason With a Bang: Three Trades Over Four Days
Seattle Mariners Start Offseason With a Bang: Three Trades Over Four Days
MLB Commissioner: New Rule for Pace-of-Play in 2018
MLB Commissioner: New Rule for Pace-of-Play in 2018
Alex Cobb Could Be Good Fit for Cubs
Alex Cobb Could Be Good Fit for Cubs
Joey Votto Is One of Baseball’s Best Hitters
Joey Votto Is One of Baseball’s Best Hitters
Hunter Pence May Become Part-Time Player
Hunter Pence May Become Part-Time Player
Perfect 300 Bowled by Red Sox Right Fielder Mookie Betts
Perfect 300 Bowled by Red Sox Right Fielder Mookie Betts


Leave a Reply

 
© 2006-2017 BBNS.